Unknown

Dataset Information

0

Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.


ABSTRACT: We performed a study to investigate the role of ERCC1, ERCC2, ERCC5, XPA and XPC polymorphisms from perspective of the whole NER pathway in the prognosis of gastric cancer. A total of 410 gastric cancer patients were recruited between January 2010 and December 2011. Restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR) was used to analyze genotypes of ERCC1 rs11615 and rs3212986, ERCC2 rs13181 and s1799793, ERCC5 rs17655, XPA rs1800975 and XPC rs2228001. Our study found that carriers of ERCC1 rs3212986 TT genotype showed significantly favorable survival than wide-type GG genotype in multivariate analysis (OR=6.38, 95% CI=2.54-19.03), and patients with variant CC genotype of ERCC2 rs13181 exhibited better response to chemotherapy than those with AA genotype (OR=2.21, 95% CI=1.17-4.25). By Cox proportional hazards model, patients with variant TT genotype of ERCC1 rs3212986 exhibited longer PFS and OS than those who had GG genotype (for PFS, HR=0.37, 95% CI=0.17-0.75; for OS, HR=0.36, 95% CI=0.13-0.87). For ERCC2 rs13181 polymorphism, carriers with CC genotype demonstrated significantly increased hazards of progression of disease and death in multivariate model (for PFS, HR=0.48, 95% CI=0.26-0.88; for OS, HR=0.44, 95% CI=0.20-0.91). In conclusion, our finding suggests that ERCC1 rs3212986 and ERCC2 rs13181 gene polymorphism could influence the response to chemotherapy and clinical outcome of gastric cancer.

SUBMITTER: Xue MH 

PROVIDER: S-EPMC4503136 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.

Xue Ming-Hui MH   Li Guang-Yan GY   Wu Xin-Jun XJ   Zhang Chao-Xian CX   Zhang Cai-Feng CF   Zhu Kong-Xi KX  

International journal of clinical and experimental pathology 20150501 5


We performed a study to investigate the role of ERCC1, ERCC2, ERCC5, XPA and XPC polymorphisms from perspective of the whole NER pathway in the prognosis of gastric cancer. A total of 410 gastric cancer patients were recruited between January 2010 and December 2011. Restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR) was used to analyze genotypes of ERCC1 rs11615 and rs3212986, ERCC2 rs13181 and s1799793, ERCC5 rs17655, XPA rs1800975 and XPC rs2228001. Our study found t  ...[more]

Similar Datasets

| S-EPMC4680487 | biostudies-literature
| S-EPMC4579803 | biostudies-literature
| S-EPMC4466986 | biostudies-literature
| S-EPMC5217006 | biostudies-literature
| S-EPMC2795613 | biostudies-literature
| S-EPMC3858487 | biostudies-literature
| S-EPMC5075267 | biostudies-literature
| S-EPMC4637710 | biostudies-literature
| S-EPMC4095777 | biostudies-literature
| S-EPMC7595902 | biostudies-literature